Current and historical daily PE Ratio for Biotechnology Assets (
STU:041
) from 2018 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Biotechnology Assets stock (STU:041) PE ratio as of Jun 19 2024 is 13.33.
More Details
Biotechnology Assets SA (STU:041) PE Ratio (TTM) Chart
Biotechnology Assets SA (STU:041) PE Ratio (TTM) Historical Data
View and export this data going back to 2018. Start your Free Trial
Total 1290
- 1
- 2
- 3
- 4
- 5
- 6
- 15
| Biotechnology Assets PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-06-20 | 9.3 | 2024-04-16 | 10.6 |
| 2024-06-18 | 9.3 | 2024-04-15 | 9.8 |
| 2024-06-17 | 9.4 | 2024-04-12 | 11.0 |
| 2024-06-14 | 9.6 | 2024-04-11 | 10.1 |
| 2024-06-13 | 9.5 | 2024-04-10 | 10.1 |
| 2024-06-12 | 9.2 | 2024-04-09 | 10.1 |
| 2024-06-11 | 10.2 | 2024-04-08 | 10.2 |
| 2024-06-10 | 10.6 | 2024-04-05 | 10.1 |
| 2024-06-07 | 9.7 | 2024-04-04 | 9.9 |
| 2024-06-06 | 11.2 | 2024-04-03 | 10.0 |
| 2024-06-05 | 8.9 | 2024-04-02 | 10.2 |
| 2024-06-04 | 8.9 | 2024-03-28 | 11.2 |
| 2024-06-03 | 8.7 | 2024-03-27 | 11.1 |
| 2024-05-31 | 9.9 | 2024-03-26 | 10.2 |
| 2024-05-30 | 10.1 | 2024-03-25 | 11.3 |
| 2024-05-29 | 9.7 | 2024-03-22 | 10.4 |
| 2024-05-28 | 9.8 | 2024-03-21 | 10.6 |
| 2024-05-27 | 9.8 | 2024-03-20 | 10.3 |
| 2024-05-24 | 8.7 | 2024-03-19 | 10.4 |
| 2024-05-23 | 9.8 | 2024-03-18 | 10.4 |
| 2024-05-22 | 9.9 | 2024-03-15 | 10.4 |
| 2024-05-21 | 9.8 | 2024-03-14 | 11.5 |
| 2024-05-20 | 9.8 | 2024-03-13 | 10.4 |
| 2024-05-17 | 9.9 | 2024-03-12 | 10.4 |
| 2024-05-16 | 9.0 | 2024-03-11 | 10.7 |
| 2024-05-15 | 9.0 | 2024-03-08 | 10.8 |
| 2024-05-14 | 9.2 | 2024-03-07 | 10.7 |
| 2024-05-13 | 8.8 | 2024-03-06 | 10.3 |
| 2024-05-10 | 10.0 | 2024-03-05 | 10.6 |
| 2024-05-09 | 9.7 | 2024-03-04 | 10.3 |
| 2024-05-08 | 8.5 | 2024-03-01 | 10.5 |
| 2024-05-07 | 8.7 | 2024-02-29 | 10.7 |
| 2024-05-06 | 8.9 | 2024-02-28 | 11.9 |
| 2024-05-03 | 8.4 | 2024-02-27 | 11.7 |
| 2024-05-02 | 8.7 | 2024-02-26 | 10.6 |
| 2024-04-30 | 9.9 | 2024-02-23 | 10.7 |
| 2024-04-29 | 9.2 | 2024-02-22 | 11.0 |
| 2024-04-26 | 9.3 | 2024-02-21 | 10.8 |
| 2024-04-25 | 9.5 | 2024-02-20 | 10.8 |
| 2024-04-24 | 9.0 | 2024-02-19 | 10.6 |
| 2024-04-23 | 9.1 | 2024-02-16 | 11.7 |
| 2024-04-22 | 8.9 | 2024-02-15 | 10.7 |
| 2024-04-19 | 9.6 | 2024-02-14 | 10.8 |
| 2024-04-18 | 9.7 | 2024-02-13 | 11.2 |
| 2024-04-17 | 9.3 | 2024-02-12 | 10.6 |
Biotechnology Assets SA (STU:041) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Biotechnology Assets SA
NAICS : 325411
SIC : 2834
ISIN : ES0184980003
Compare
Compare
Traded in other countries / regions
BST.Spain041.Germany IPO Date
2018-05-22Description
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers